I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Dueñas-Gonzalez, Alfonso
527
results:
Articles (Online) X
Search for persons
X
Languages
english (458)
spanish (10)
Sorted by: Relevance
Sorted by: Year
?
1
Risk of death derived from Hazard Ratio should not be commu..:
Dueñas-Gonzalez, Alfonso
Qeios. , 2024
Link:
https://doi.org/10.32388..
?
2
Does Therapeutic Repurposing in Cancer Meet the Expectation..:
Gonzalez-Fierro, Aurora
;
Romo-Pérez, Adriana
;
Chávez-Blanco, Alma
..
Clinical Drug Investigation. 43 (2023) 4 - p. 227-239 , 2023
Link:
https://doi.org/10.1007/..
?
3
Selection of clinically relevant drug concentrations for in..:
Robles-Bañuelos, Benjamin
;
Romo-Perez, Adriana
;
Dominguez-Gomez, Guadalupe
...
Clinical and Translational Oncology. 26 (2023) 5 - p. 1077-1088 , 2023
Link:
https://doi.org/10.1007/..
?
4
Risk of death derived from Hazard Ratio should not be commu..:
Dueñas-Gonzalez, Alfonso
Qeios. , 2023
Link:
https://doi.org/10.32388..
?
5
Hazard Risk Reductions Should Not Be Communicated as Relati..:
Dueñas-Gonzalez, Alfonso
Qeios. , 2023
Link:
https://doi.org/10.32388..
?
6
The health system and access to treatment in patients with ..:
Arango-Bravo, Eder A.
;
Cetina-Pérez, Lucely del Carmen
;
Galicia-Carmona, Tatiana
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
7
Antimetastatic Effect of Epigenetic Drugs, Hydralazine and ..:
Pérez-Cárdenas, Enrique
;
Taja-Chayeb, Lucía
;
Trejo-Becerril, Catalina
...
OncoTargets and Therapy. 15 (2022) - p. 845-846 , 2022
Link:
https://doi.org/10.2147/..
?
8
Drug repurposing for cancer therapy, easier said than done:
Gonzalez-Fierro, Aurora
;
Dueñas-González, Alfonso
Seminars in Cancer Biology. 68 (2021) - p. 123-131 , 2021
Link:
https://doi.org/10.1016/..
?
9
Rituximab in combination with cyclophosphamide, doxorubicin..:
Candelaria, Myrna
;
Dueñas-Gonzalez, Alfonso
Therapeutic Advances in Hematology. 12 (2021) - p. 204062072198957 , 2021
Link:
https://doi.org/10.1177/..
?
10
Pharmacological inhibition of tumor anabolism and host cata..:
Schcolnik-Cabrera, Alejandro
;
Chavez-Blanco, Alma
;
Dominguez-Gomez, Guadalupe
...
Scientific Reports. 11 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1038/..
?
11
In Vitro Employment of Recombinant Taenia solium Calreticul..:
Schcolnik-Cabrera, Alejandro
;
Juárez, Mandy
;
Oldak, Bernardo
...
Archives of Medical Research. 51 (2020) 1 - p. 65-75 , 2020
Link:
https://doi.org/10.1016/..
?
12
Barriers for Pharmaceutical Innovation With Focus in Cancer..:
Duenas-Gonzalez, Alfonso
;
Gonzalez-Fierro, Aurora
Therapeutic Innovation & Regulatory Science. 54 (2020) 2 - p. 342-352 , 2020
Link:
https://doi.org/10.1007/..
?
13
Antitumor effects of ivermectin at clinically feasible conc..:
Juarez, Mandy
;
Schcolnik-Cabrera, Alejandro
;
Dominguez-Gomez, Guadalupe
...
Cancer Chemotherapy and Pharmacology. 85 (2020) 6 - p. 1153-1163 , 2020
Link:
https://doi.org/10.1007/..
?
14
Barriers for Pharmaceutical Innovation With Focus in Cancer..:
Duenas-Gonzalez, Alfonso
;
Gonzalez-Fierro, Aurora
Therapeutic Innovation & Regulatory Science. , 2019
Link:
https://doi.org/10.1177/..
?
15
Antimetastatic effect of epigenetic drugs, hydralazine and ..:
Pérez-Cárdenas, Enrique
;
Taja-Chayeb, Lucía
;
Trejo-Becerril, Catalina
...
OncoTargets and Therapy. 11 (2018) - p. 8823-8833 , 2018
Link:
https://doi.org/10.2147/..
1-15